Breast and prostate cancer
Aspects concerning co-morbidity; patterns of drug use, long-term survival
The aim of this project was to study aspects of co-morbidity; patterns of use of prescribed drugs; and long term survival in patients with advanced disease at diagnosis.
Background: Reasons for non-adherence to management guidelines for breast- and prostate cancer are not always clear, but may be attributed to concomitant disease. Also, co morbidity burden may represent one explanation for social gradients in survival. - Little is known about patterns of drug use in cancer patients. - Long term survival in cancer patients with advanced disease raise questions about diagnostic accuracy and whether these patients have special characteristics.
Material: Clinical Quality Registers on Prostate and Breast Cancer, the Register of Prescribed Pharmaceuticals and other databases.
Project period: 2009-2014
Main financing: The Swedish Cancer Society, the Swedish Council for Working Life and Social Research.
Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden.
J. Urol. 2011 Mar;185(3):833-9
Impact of comorbidity on management and mortality in women diagnosed with breast cancer.
Breast Cancer Res. Treat. 2012 Aug;135(1):281-9